Showing results (1751-1760 of 3,570) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|September 16, 2026
Thrombotic and ischemic event reporting with anticoagulant reversal agents: a multi-agent FAERS pharmacovigilance studyHasan Burak Isleyen, Sevil Tugrul Yavuz, Nusret Acikgoz, et al.Journal of Thrombosis and Thrombolysis|September 16, 2026
Evaluation of the Pulmonary Embolism Comprehensive Screening Scoring (PECSS) using multi-center emergency cohortsLuojia Tang, Yundi Hu, Hua Wang, et al.Journal of Thrombosis and Thrombolysis|September 23, 2026
miR-224-5p alleviates oxygen-glucose deprivation/reperfusion injury via regulating FASYanping Zhu, Haitao Fang, Yawen Zhang, et al.Journal of Thrombosis and Thrombolysis|August 13, 2003
Pharmacologic reperfusion therapy for acute myocardial infarctionHarry C Lowe, Briain D Mac Neill, Frans Van de Werf, et al.Journal of Thrombosis and Thrombolysis|August 13, 2003
Lack of alpha 2-antiplasmin enhances ADP induced platelet micro-aggregation through the presence of excess active plasmin in miceMariko Takei, Hiroyuki Matsuno, Kiyotaka Okada, et al.Journal of Thrombosis and Thrombolysis|August 13, 2003
Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of diseaseHakan Ekmekci, Huseyin Sonmez, Ozlem B Ekmekci, et al.Journal of Thrombosis and Thrombolysis|August 13, 2003
Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarctionC Michael Gibson, James A de Lemos, Sabina A Murphy, et al.Journal of Thrombosis and Thrombolysis|June 14, 2022
Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort studyBrian D Adkins, Hila Shaim, Abdul Abid, et al.Journal of Thrombosis and Thrombolysis|January 29, 2011
Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failureAndrea Lee, Mark CrowtherJournal of Thrombosis and Thrombolysis|January 15, 2011
Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertaintiesFederico CacciapuotiPageof 357